Laparoscopic major hepatectomy for hepatocellular carcinoma in elderly patients: a multicentric propensity score-based analysis

Background Considering the increase in overall life expectancy and the rising incidence of hepatocellular carcinoma (HCC), more elderly patients are considered for hepatic resection. Traditionally, major hepatectomy has not been proposed to the elderly due to severe comorbidities. Indeed, only a few case series are reported in the literature. The present study aimed to compare short-term and long-term outcomes between laparoscopic major hepatectomy (LMH) and open major hepatectomy (OMH) in elderly patients with HCC using propensity score matching (PSM). Methods We performed a multicentric retrospective study including 184 consecutive cases of HCC major liver resection in patients aged >= 70 years in _8 European Hospital Centers. Patients were divided into LMH and OMH groups, and perioperative and long-term outcomes were compared between the 2 groups. Results After propensity score matching, 122 patients were enrolled, 38 in the LMH group and 84 in the OMH group. Postoperative overall complications were lower in the LMH than in the OMH group (18 vs. 46%,p < 0.001). Hospital stay was shorter in the LMH group than in the OMH group (5 vs. 7 days,p = 0.01). Mortality at 90 days was comparable between the two groups. There were no significant differences between the two groups in terms of overall survival (OS) and disease-free survival (DFS) at 1, 3, and 5 years. Conclusion LMH for HCC is associated with appropriate short-term outcomes in patients aged >= 70 years as compared to OMH. LMH is safe and feasible in elderly patients with HCC.

Automated summary

This study compared short-term and long-term outcomes between laparoscopic major hepatectomy (LMH) and open major hepatectomy (OMH) in elderly patients with HCC, showing that LMH had lower postoperative complications and shorter hospital stay compared to OMH, with comparable mortality rates at 90 days and overall survival rates at 1, 3, and 5 years. The study concluded that LMH is safe and feasible in elderly patients with HCC.